NCT01692145View on ClinicalTrials.gov

A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Dry Eye Syndromes
Interventions
DRUG

KCT-0809

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY